Context Therapeutics - Edison Group

Popular Searches:

Your Previous Searches:

Recently Visited Pages:

Home
Sparks
Equities
Equities
View All Equities
Equities by Sector

Consumer

Energy & Resources

Financials

Healthcare

Industrials

Investment Companies

Metals & Mining

Real Estate

TMT

YXT.com

MCap

USD127m

Last close

USD23.43

▲ 20.23 (632.19%)

Northern Data Group

MCap

EUR486m

Last close

EUR7.56

▲ 2.33 (44.59%)

Bodycote

MCap

GBP1,572m

Last close

GBP9.14

▲ −9.00 (−0.98%)
Sectors
Sectors
Megatrends
Megatrends
- Artificial intelligence
Thematics
Thematics
View All Thematics

Latest
Audiovisual
Audiovisual
View All Audiovisual

Latest

Events
About Edison
About Edison
Corporates

Investors

Careers

“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”

Edison Client
Equity Research
Investor Relations
Contact us

Context Therapeutics (NASDAQ: CNTX)

Last close As at 05/08/2026

—

— 0.00 (0.00%)

Market capitalisation

—

Overview
Research
Sector insights
Thematics

Latest Insights

View More

Healthcare |
Flash note

11.05.23

Context Therapeutics — FY23 focus squarely on CTIM-76

Healthcare |
edison tv

20.04.23

Context Therapeutics webinar: Claudin 6 x CD3 bispecific antibody data update

Healthcare |
Update

19.04.23

Context Therapeutics — R&D webinar highlights CTIM-76’s potential

Healthcare |
Flash note

23.03.23

Context Therapeutics — Strategic pivot in pipeline focus

Doctor with cancer patient

Market Data

Share Price —

Market Cap —

52-Week High —

52-Week Low —

% Change 1M

% Change 6M —

% Change 12M

Ave. Daily Volume 1yr —

Update

Healthcare

10.11.22

Context Therapeutics — Period marked by readouts and pipeline progress

Update

Healthcare

28.09.22

Context Therapeutics — Cash runway extended to Q124

Update

Healthcare

12.08.22

Context Therapeutics — Anticipating a catalyst rich Q422

mockup-graphics--msTEzGwKJs-unsplash

Update

Healthcare

02.08.22

Context Therapeutics — Promising combination therapy for ONA-XR

Update

Healthcare

26.05.22

Context Therapeutics — Q122 progress in line with development strategy

Update

Healthcare

22.04.22

Context Therapeutics — R&D webinar highlights pipeline potential

edison tv

Healthcare

22.04.22

Key opinion leader webinar: Context Therapeutics

Update

Healthcare

08.04.22

Context Therapeutics — A catalyst-rich year ahead

mockup-graphics--msTEzGwKJs-unsplash

Initiation

Healthcare

24.02.22

Context Therapeutics — Women’s oncology play with a novel pipeline

edison tv

Healthcare

10.02.22

Context Therapeutics: Edison Open House Healthcare 2022